Literature DB >> 30550217

[Uvuplopalatal flap in OSAHS patients with anteriorand posterior pharyngeal plane stenosis].

J H Jin1, S X Huang1, Y Y Liang1, Z Z Cui1.   

Abstract

Objective: Observation of the effect of uvuplopalatal flap for OSAHS patients with anterior and posterior pharyngeal stenosis. Method: Fifty-six patients with OSAHS who were mainly anterior posterior stenosis in the velopharyngeal plane were selected. Patients with suspending uvuplopalatal flap were used as observation group (30 cases). Patients with UPPP were used as control group (26 cases). The investigation and comparison of AHI, SaO₂, scars, throat foreign body sensation, pharynx desiccation, pharynx' s tightness, pharynx discomfort and surgical satisfaction were investigated at 6-8 months after the operation. Restul: At 6-8 months after operation, the AHI and SaO₂ of the two groups were significantly improved compared with those before operation(P<0.01). However, there were significant differences(P<0.01) among the indexes of scar formation, throat foreign body, sensation pharynx desiccation, pharynx' s tightness, pharynx discomfort and surgical satisfaction.
Conclusion: In the OSAHS patients with anterior and posterior pharyngeal stenosis, the effect of UPF was better than that of UPPP among the indexes of scar formation, pharyngeal symptoms and surgical satisfaction. Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.

Entities:  

Keywords:  sleep apnea hypopnea syndrome,obstructive; uvulopalatopharyngoplasty; uvuplopalatal flap

Year:  2018        PMID: 30550217     DOI: 10.13201/j.issn.1001-1781.2018.23.012

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  1 in total

1.  Effect of Simultaneous Multiplane Surgery on Cardiopulmonary Function in Patients with Moderate to Severe Obstructive Sleep Apnea-Hypopnea Syndrome and Its Curative Effect.

Authors:  Mingjie Gong; Jingwen Shao
Journal:  Biomed Res Int       Date:  2022-09-15       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.